Renaissance Venture Capital

Renaissance Venture Capital Management, Inc. is a venture capital firm based in Ann Arbor, Michigan, founded in 2008. The firm specializes in both direct investments in early, mid, and late-stage ventures, as well as fund of funds investments in venture capital funds. Renaissance focuses on companies located in the United States, with a particular emphasis on those in Michigan, and actively seeks co-investment opportunities with emerging companies in the state. The firm typically invests between $0.5 million and $1 million in its portfolio companies. Renaissance aims to foster economic growth in Michigan by bridging the gap between the state's innovation sector and its industrial and commercial base, supporting the development of strong innovative companies within the region.

Christina Drake

Partner

Vincent Nystrom

Partner

Jeffrey Rinvelt

Principal

Christopher Rizik

Founder, CEO and Managing Partner

12 past transactions

Strata Oncology

Series C in 2021
Strata Oncology, Inc. is a precision oncology company focused on improving cancer care by increasing patient access to clinical trials and expediting drug approvals. The company operates a national precision oncology platform that connects patient screening to streamlined enrollment in mutation-matched clinical trials. Strata collaborates with major healthcare systems to facilitate the genomic sequencing of cancer patients' biopsies in high-throughput laboratories, providing oncologists with timely tumor profiles that inform treatment decisions. Its offerings include The Strata Trial, StrataNGS for targeted DNA and RNA sequencing, and StrataPOINT, which integrates electronic medical records with molecular data to ensure comprehensive testing and follow-up for eligible patients. Strata also manages a portfolio of pharmaceutical-sponsored trials tailored to specific biomarkers and operates the Strata Precision Oncology Network, a collaborative effort among cancer centers to advance precision medicine. Founded in 2015 and headquartered in Ann Arbor, Michigan, Strata was previously known as Strata Oncology Research, Inc. until its name change in May 2016.

Autobooks

Series B in 2021
Autobooks, Inc. is a provider of integrated payment and accounting software designed for small businesses and delivered through financial institutions. Founded in 2015 and based in Detroit, Michigan, Autobooks offers a cloud-based platform that simplifies the management of cash flow and automates accounting processes. The platform enables small businesses to easily receive payments online, reconcile accounts, and access tools for invoicing, bill payment, and merchant services. By embedding its services within existing digital banking channels, Autobooks allows financial institutions to enhance their offerings and provide essential back-office support for their small business clients. The company, which was previously known as Automated Booking, Inc., rebranded to Autobooks, Inc. in March 2018.

Strata Oncology

Series B in 2018
Strata Oncology, Inc. is a precision oncology company focused on improving cancer care by increasing patient access to clinical trials and expediting drug approvals. The company operates a national precision oncology platform that connects patient screening to streamlined enrollment in mutation-matched clinical trials. Strata collaborates with major healthcare systems to facilitate the genomic sequencing of cancer patients' biopsies in high-throughput laboratories, providing oncologists with timely tumor profiles that inform treatment decisions. Its offerings include The Strata Trial, StrataNGS for targeted DNA and RNA sequencing, and StrataPOINT, which integrates electronic medical records with molecular data to ensure comprehensive testing and follow-up for eligible patients. Strata also manages a portfolio of pharmaceutical-sponsored trials tailored to specific biomarkers and operates the Strata Precision Oncology Network, a collaborative effort among cancer centers to advance precision medicine. Founded in 2015 and headquartered in Ann Arbor, Michigan, Strata was previously known as Strata Oncology Research, Inc. until its name change in May 2016.

Cirius Therapeutics

Series A in 2017
Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to developing and commercializing therapies for liver and metabolic diseases. Founded in 2015 and headquartered in San Diego, California, the company focuses on its lead product candidate, MSDC-0602K, an oral small molecule currently undergoing Phase 2b clinical trials for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis. This next-generation insulin sensitizer aims to address the underlying pathophysiology of NASH, a condition characterized by fat accumulation and inflammation in the liver that can lead to severe complications such as cirrhosis and liver cancer. Cirius Therapeutics is committed to providing innovative solutions to healthcare providers for managing liver and metabolic diseases.

Millendo Therapeutics

Series B in 2016
Millendo Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for endocrine diseases resulting from hormone dysregulation. The company focuses on addressing significant unmet medical needs by creating distinct therapies that improve clinical care. By leveraging scientific advancements, Millendo aims to develop novel compounds that can effectively treat complex conditions, ultimately enhancing the quality of life for patients, families, and caregivers.

ArborMetrix

Series B in 2014
ArborMetrix, Inc. is a data analytics and technology company focused on enhancing healthcare outcomes and advancing research through its innovative platform. Founded in 2011 and headquartered in Ann Arbor, Michigan, ArborMetrix offers a range of solutions for the healthcare industry, including data collection and integration, performance measurement, and analytics. Its products, such as EpisodeMetrix, provide critical insights into payer claims data, helping healthcare payers and at-risk providers manage costs and improve specialty care quality. The company also offers RegistryMetrix, which allows for the creation of specialized clinical registries, and SurgicalMetrix, which analyzes the performance of surgical groups by integrating clinical, financial, and operational data. ArborMetrix serves a diverse clientele that includes specialty societies, medical device manufacturers, pharmaceutical companies, and health systems, delivering actionable insights to optimize clinical outcomes and financial performance.

Swift Biosciences

Series B in 2013
Swift Biosciences, Inc. develops molecular biology reagents for research and diagnostic applications. Swift Biosciences, Inc. is based in Ann Arbor, Michigan.

Fidelis SeniorCare

Series A in 2013
Fidelis SeniorCare, Inc., a managed care company, develops and administers health plans for assisted living residents in Michigan, North Carolina, and Texas. The company offers Medicare advantage special needs plans to cover the health needs of seniors living in nursing homes and assisted living communities; and individuals who require specialized healthcare. Its plans cover on-site primary care team visits, part D prescription drugs, monitoring and managing prescribed medications, transportation to the hospital or physician’s office, and skilled nursing services during a covered Medicare stay; preventive care, screening, vision/dental/hearing, and podiatry services; and emergency room, ambulance, and urgent care services. The company was founded in 2004 and is based in Schaumburg, Illinois.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.